Publication in DIABETES
Aixin Yu et al., Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes, Diabetes June 2015 64:6 2172-2183


DIABIL-2 at the IDS congress  - April 2015

The Immunology of Diabetes Society 14th International Congress tok place in Munich on 12-16 April 2015. DIABIL-2co-sponsored a session on Sunday 12th April: “Targeting a cytokine pathway”.


DIABIL-2 2nd Annual Meeting - 10 & 11 October 2014

DIABIL-2 partners gathered in Paris on 10th - 11th October 2014 for the 2nd Annual Meeting. This was also the occasion to bring together the clinical centres that are participating in the DIABIL-2 European trial to be launched in the coming months.


Publication in The Lancet Diabetes & Endocrinology

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. Click here to view more.


DIABIL-2 1st General meeting in Basel on November 12th and 13th 2013
This meeting gathered all DIABIL-2 partners from UK, Germany, Switzerland and France for presenting the progress made since the launch of the project a year ago as well as the next achievements for the forthcoming year. The meeting took place in the presence of the members of the Independent Scientific Advisory Board of the project, who will carefully monitor and advise us in our activities.